Microbot Medical INC S-1 registration statements

Microbot Medical Inc. files an amendment to its Form S-1 registration statement with the SEC, indicating a continuous offering of securities.

Microbot Medical is registering for the resale of up to 15.9 million shares of its common stock, which are issuable upon the exercise of outstanding preferred investment options held by selling stockholders.

Microbot Medical has filed an amendment to its S-1 registration statement, covering the resale of up to 3,211,671 shares of common stock by selling stockholders upon exercise of preferred investment options.

Microbot Medical is registering for the resale of up to 3.2 million shares of its common stock, issuable upon the exercise of outstanding preferred investment options held by selling stockholders.

Microbot Medical has filed an amendment to its Form S-1 registration statement, pertaining to the resale of up to 1,005,965 shares of its common stock by selling stockholders, primarily related to the settlement of a lawsuit.

Microbot Medical is registering the resale of 1,005,965 shares of its common stock by selling stockholders following a settlement agreement.

Microbot Medical offers new preferred investment options and a reduced exercise price to holders in exchange for exercising existing options.

Microbot Medical has filed a registration statement for the potential resale of up to 1,769,966 shares of its common stock, issuable upon the exercise of outstanding preferred investment options held by selling stockholders.